Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial

Taghreed Hirz1,2,3, Shenglin Mei4,5, Hirak Sarkar6

  • 1Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA. THIRZ@mgh.harvard.edu.

Nature Communications
|February 7, 2023
PubMed

Insights

This study details the prostate tumor microenvironment, revealing immune suppressive cells and high angiogenic activity in high-risk prostate cancer. Understanding these factors is crucial for developing new treatments to prevent disease recurrence and metastasis.

Area of Science:

  • Oncology
  • Immunology
  • Genomics

Background:

  • Prostate cancer recurrence and metastasis are significant clinical challenges.
  • The underlying mechanisms driving immune escape and tumor progression remain poorly understood.
  • Effective treatment strategies for high-risk prostate cancer require a deeper insight into the tumor microenvironment.

Purpose of the Study:

  • To comprehensively characterize the tumor microenvironment (TME) in localized prostate cancer.
  • To compare the TME of prostate tumors with adjacent normal tissues and healthy controls.
  • To identify key cellular and molecular components contributing to immune suppression and tumor progression.

Main Methods:

  • Single-cell RNA sequencing (scRNA-seq) for gene expression analysis.
  • High-resolution spatial transcriptomics to map cellular architecture.
  • Ligand-receptor interaction analysis to infer cell-to-cell communication.

Main Results:

  • Identified an immune-suppressive TME associated with suppressive myeloid cells and exhausted T-cells.
  • Observed high stromal angiogenic activity within the tumor microenvironment.
  • Revealed tumor context-dependent alterations in gene expression and cell-cell interactions.

Conclusions:

  • The prostate tumor microenvironment exhibits distinct immune-suppressive characteristics.
  • Stromal angiogenic activity and specific immune cell populations contribute to tumor progression.
  • This study provides a detailed resource for understanding prostate cancer TME and cell interactions, aiding future therapeutic development.